These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15279718)

  • 1. 13-cis-retinoic acid in the treatment of recurrent glioblastoma multiforme.
    See SJ; Levin VA; Yung WK; Hess KR; Groves MD
    Neuro Oncol; 2004 Jul; 6(3):253-8. PubMed ID: 15279718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of recurrent malignant gliomas with high-dose 13-cis-retinoic acid.
    Yung WK; Kyritsis AP; Gleason MJ; Levin VA
    Clin Cancer Res; 1996 Dec; 2(12):1931-5. PubMed ID: 9816151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
    Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
    J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-alpha2a and 13-cis-retinoic acid with radiation treatment for high-grade glioma.
    Dillman RO; Shea WM; Tai DF; Mahdavi K; Barth NM; Kharkar BR; Poor MM; Church CK; DePriest C
    Neuro Oncol; 2001 Jan; 3(1):35-41. PubMed ID: 11305415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage therapy in patients with glioblastoma: is there any benefit?
    Hau P; Baumgart U; Pfeifer K; Bock A; Jauch T; Dietrich J; Fabel K; Grauer O; Wismeth C; Klinkhammer-Schalke M; Allgäuer M; Schuierer G; Koch H; Schlaier J; Ulrich W; Brawanski A; Bogdahn U; Steinbrecher A
    Cancer; 2003 Dec; 98(12):2678-86. PubMed ID: 14669289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
    Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
    Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
    Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy with 13-cis-retinoic acid and celecoxib in the treatment of glioblastoma multiforme.
    Levin VA; Giglio P; Puduvalli VK; Jochec J; Groves MD; Yung WK; Hess K
    J Neurooncol; 2006 May; 78(1):85-90. PubMed ID: 16391896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults.
    Kesari S; Schiff D; Doherty L; Gigas DC; Batchelor TT; Muzikansky A; O'Neill A; Drappatz J; Chen-Plotkin AS; Ramakrishna N; Weiss SE; Levy B; Bradshaw J; Kracher J; Laforme A; Black PM; Folkman J; Kieran M; Wen PY
    Neuro Oncol; 2007 Jul; 9(3):354-63. PubMed ID: 17452651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role for cytotoxic chemotherapy in patients with recurrent glioblastoma progressing on bevacizumab: a retrospective case series.
    Chamberlain MC
    Expert Rev Neurother; 2012 Aug; 12(8):929-36. PubMed ID: 23002937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.
    Norden AD; Young GS; Setayesh K; Muzikansky A; Klufas R; Ross GL; Ciampa AS; Ebbeling LG; Levy B; Drappatz J; Kesari S; Wen PY
    Neurology; 2008 Mar; 70(10):779-87. PubMed ID: 18316689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nimustine (ACNU) plus teniposide (VM26) in recurrent glioblastoma.
    Glas M; Hundsberger T; Stuplich M; Wiewrodt D; Kurzwelly D; Nguyen-Huu B; Rasch K; Herrlinger U
    Oncology; 2009; 76(3):184-9. PubMed ID: 19218824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patupilone (epothilone B) for recurrent glioblastoma: clinical outcome and translational analysis of a single-institution phase I/II trial.
    Oehler C; Frei K; Rushing EJ; McSheehy PM; Weber D; Allegrini PR; Weniger D; Lütolf UM; Knuth A; Yonekawa Y; Barath K; Broggini-Tenzer A; Pruschy M; Hofer S
    Oncology; 2012; 83(1):1-9. PubMed ID: 22688083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme.
    Reardon DA; Egorin MJ; Quinn JA; Rich JN; Gururangan S; Vredenburgh JJ; Desjardins A; Sathornsumetee S; Provenzale JM; Herndon JE; Dowell JM; Badruddoja MA; McLendon RE; Lagattuta TF; Kicielinski KP; Dresemann G; Sampson JH; Friedman AH; Salvado AJ; Friedman HS
    J Clin Oncol; 2005 Dec; 23(36):9359-68. PubMed ID: 16361636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KRN8602 (MX2-hydrochloride): an active new agent for the treatment of recurrent high-grade glioma.
    Clarke K; Basser RL; Underhill C; Mitchell P; Bartlett J; Cher L; Findlay M; Dalley D; Pell M; Byrne M; Geldard H; Hill JS; Maher D; Fox RM; Green MD; Kaye AH
    J Clin Oncol; 1999 Aug; 17(8):2579-84. PubMed ID: 10561325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of Cloretazine for the treatment of adults with recurrent glioblastoma multiforme.
    Badruddoja MA; Penne K; Desjardins A; Reardon DA; Rich JN; Quinn JA; Sathornsumetee S; Friedman AH; Bigner DD; Herndon JE; Cahill A; Friedman HS; Vredenburgh JJ
    Neuro Oncol; 2007 Jan; 9(1):70-4. PubMed ID: 17108065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance therapy with 13-cis retinoid acid in high-grade glioma at complete response after first-line multimodal therapy--a phase-II study.
    Wismeth C; Hau P; Fabel K; Baumgart U; Hirschmann B; Koch H; Jauch T; Grauer O; Drechsel L; Brawanski A; Bogdahn U; Steinbrecher A
    J Neurooncol; 2004 May; 68(1):79-86. PubMed ID: 15174524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme.
    Chang SM; Wen P; Cloughesy T; Greenberg H; Schiff D; Conrad C; Fink K; Robins HI; De Angelis L; Raizer J; Hess K; Aldape K; Lamborn KR; Kuhn J; Dancey J; Prados MD;
    Invest New Drugs; 2005 Aug; 23(4):357-61. PubMed ID: 16012795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suramin and radiotherapy in newly diagnosed glioblastoma: phase 2 NABTT CNS Consortium study.
    Laterra JJ; Grossman SA; Carson KA; Lesser GJ; Hochberg FH; Gilbert MR;
    Neuro Oncol; 2004 Jan; 6(1):15-20. PubMed ID: 14769135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.